Cargando…

Use of psychiatric drugs in Dermatology()()

Patients with psychocutaneous disorders often refuse psychiatric intervention in their first consultations, leaving initial management to the dermatologist. The use of psychotropic agents in dermatological practice, represented by antidepressants, antipsychotics, anxiolytics, and mood stabilizers, s...

Descripción completa

Detalles Bibliográficos
Autores principales: Weber, Magda Blessmann, Recuero, Júlia Kanaan, Almeida, Camila Saraiva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Dermatologia 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175395/
https://www.ncbi.nlm.nih.gov/pubmed/32171543
http://dx.doi.org/10.1016/j.abd.2019.12.002
_version_ 1783524825992527872
author Weber, Magda Blessmann
Recuero, Júlia Kanaan
Almeida, Camila Saraiva
author_facet Weber, Magda Blessmann
Recuero, Júlia Kanaan
Almeida, Camila Saraiva
author_sort Weber, Magda Blessmann
collection PubMed
description Patients with psychocutaneous disorders often refuse psychiatric intervention in their first consultations, leaving initial management to the dermatologist. The use of psychotropic agents in dermatological practice, represented by antidepressants, antipsychotics, anxiolytics, and mood stabilizers, should be indicated so that patients receive the most suitable treatment rapidly. It is important for dermatologists to be familiar with the most commonly used drugs for the best management of psychiatric symptoms associated with dermatoses, as well as to manage dermatologic symptoms triggered by psychiatric disorders.
format Online
Article
Text
id pubmed-7175395
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Sociedade Brasileira de Dermatologia
record_format MEDLINE/PubMed
spelling pubmed-71753952020-04-22 Use of psychiatric drugs in Dermatology()() Weber, Magda Blessmann Recuero, Júlia Kanaan Almeida, Camila Saraiva An Bras Dermatol Continuing Medical Education Patients with psychocutaneous disorders often refuse psychiatric intervention in their first consultations, leaving initial management to the dermatologist. The use of psychotropic agents in dermatological practice, represented by antidepressants, antipsychotics, anxiolytics, and mood stabilizers, should be indicated so that patients receive the most suitable treatment rapidly. It is important for dermatologists to be familiar with the most commonly used drugs for the best management of psychiatric symptoms associated with dermatoses, as well as to manage dermatologic symptoms triggered by psychiatric disorders. Sociedade Brasileira de Dermatologia 2020 2020-02-18 /pmc/articles/PMC7175395/ /pubmed/32171543 http://dx.doi.org/10.1016/j.abd.2019.12.002 Text en © 2020 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Continuing Medical Education
Weber, Magda Blessmann
Recuero, Júlia Kanaan
Almeida, Camila Saraiva
Use of psychiatric drugs in Dermatology()()
title Use of psychiatric drugs in Dermatology()()
title_full Use of psychiatric drugs in Dermatology()()
title_fullStr Use of psychiatric drugs in Dermatology()()
title_full_unstemmed Use of psychiatric drugs in Dermatology()()
title_short Use of psychiatric drugs in Dermatology()()
title_sort use of psychiatric drugs in dermatology()()
topic Continuing Medical Education
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175395/
https://www.ncbi.nlm.nih.gov/pubmed/32171543
http://dx.doi.org/10.1016/j.abd.2019.12.002
work_keys_str_mv AT webermagdablessmann useofpsychiatricdrugsindermatology
AT recuerojuliakanaan useofpsychiatricdrugsindermatology
AT almeidacamilasaraiva useofpsychiatricdrugsindermatology